Stay updated with breaking news from Fred Schwarzer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MOUNTAIN VIEW, Calif., May 29, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
Shares of IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) fell 4.7% during trading on Tuesday . The stock traded as low as $8.98 and last traded at $9.10. 88,139 shares changed hands during trading, a decline of 72% from the average session volume of 310,274 shares. The stock had previously closed at $9.55. Wall […]
HC Wainwright reissued their neutral rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $12.00 target price on the stock. Other research analysts have also recently issued research reports about the company. Wedbush reiterated an outperform rating and issued a […]
IGM Biosciences, Inc. (NASDAQ:IGMS – Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $10.07, but opened at $9.85. IGM Biosciences shares last traded at $9.94, with a volume of 15,541 shares changing hands. Wall Street Analyst Weigh In IGMS has been the subject of a […]
IGM Biosciences (NASDAQ:IGMS – Get Free Report)‘s stock had its “neutral” rating reissued by equities researchers at HC Wainwright in a report released on Thursday, Benzinga reports. They presently have a $12.00 price target on the stock. HC Wainwright’s price objective suggests a potential upside of 47.60% from the company’s current price. Separately, Royal Bank […]